Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Marek Rajzer"'
Autor:
Krzysztof Narkiewicz, Aleksander Prejbisz, Andrzej Januszewicz, Katarzyna Lewandowska, Dawid Lipski, Paweł Uruski, Jacek Wolf, Marek Rajzer, Andrzej Więcek, Andrzej Tykarski
Publikováno v:
BMJ Open, Vol 14, Iss 7 (2024)
Introduction Numerous studies, but not all, have suggested a positive effect of allopurinol on the cardiovascular system. The randomised, double-blind, placebo-controlled study evaluating the effect of allopurinol on the risk of cardiovascular events
Externí odkaz:
https://doaj.org/article/5a1e1fee5e6841be8b7cc659421c45f2
Publikováno v:
Advances in Interventional Cardiology, Vol 20, Iss 2, Pp 221-223 (2024)
Externí odkaz:
https://doaj.org/article/fc5b7af7db844fcfbff9178c662f7e90
Autor:
Józefa Dąbek, Marek Styczkiewicz, Karol Kamiński, Aldona Kubica, Dariusz A. Kosior, Renata Wolfshaut-Wolak, Marek Rajzer, Magdalena Szynal, Piotr Jankowski, Zbigniew Gąsior
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 13, p 3630 (2024)
Background: The quality of life of patients with coronary heart disease is extremely important for their treatment. The aim of the study was to assess the quality of life of patients with coronary artery disease, considering education and compliance
Externí odkaz:
https://doaj.org/article/93ea9b4f42134f53b12ee78376596190
Autor:
Józefa Dąbek, Zbigniew Gąsior, Marek Styczkiewicz, Aldona Kubica, Dariusz A. Kosior, Renata Wolfshaut-Wolak, Marek Rajzer, Magdalena Szynal, Piotr Jankowski, Karol Kamiński
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 13, p 3812 (2024)
Background/Objectives: The need to conduct research on anxiety and depression in patients with coronary artery disease in connection with factors such as gender or implemented tertiary prevention is very important for drawing practical conclusions an
Externí odkaz:
https://doaj.org/article/570e8782e8ed4d4aa46aeae03d8f2e09
Publikováno v:
Healthcare, Vol 12, Iss 5, p 520 (2024)
The prevalence of calcium deposits in coronary arteries grows with age. Risk factors include, e.g., diabetes and chronic kidney disease. There are several underlying pathophysiological mechanisms of calcium deposition. Severe calcification increases
Externí odkaz:
https://doaj.org/article/4869ec3879564060893141c5e8dcb6c4
Autor:
Paweł Kozieł, Piotr Jankowski, Sławomir Surowiec, Piotr Bogacki, Piotr Gomuła, Ewa Mirek-Bryniarska, Jadwiga Nessler, Piotr Podolec, Marek Rajzer, Danuta Czarnecka
Publikováno v:
Advances in Interventional Cardiology, Vol 16, Iss 4, Pp 422-428 (2020)
Externí odkaz:
https://doaj.org/article/dc52ca0223ba410a8c1dbc77ecd5706b
Autor:
Marek Jastrzębski, Grzegorz Kiełbasa, Kamil Fijorek, Adam Bednarski, Aleksander Kusiak, Tomasz Sondej, Agnieszka Bednarek, Pawel Lis, Agnieszka Olszanecka, Marek Rajzer
Publikováno v:
Advances in Interventional Cardiology, Vol 16, Iss 4, Pp 466-473 (2020)
Externí odkaz:
https://doaj.org/article/bf6bc909b10b49a0994d7d4e4a6eb0a2
Autor:
Martijn Gerritsen, Marek Rajzer, Giovambattista Desideri, Cristina Giannattasio, Anne-Kathrin Tausche, Claudio Borghi, Michael T. Nurmohamed
Publikováno v:
European Heart Journal-Cardiovascular Pharmacotherapy, 8(3), 236-242. Oxford University Press
Desideri, G, Rajzer, M, Gerritsen, M, Nurmohamed, M T, Giannattasio, C, Tausche, A-K & Borghi, C 2022, ' Effects of intensive urate lowering therapy with febuxostat in comparison with allopurinol on pulse wave velocity in patients with gout and increased cardiovascular risk : the FORWARD study ', European heart journal. Cardiovascular pharmacotherapy, vol. 8, no. 3, pp. 236-242 . https://doi.org/10.1093/ehjcvp/pvaa144
European heart journal. Cardiovascular pharmacotherapy, 8(3), 236-242. Oxford University Press
Desideri, G, Rajzer, M, Gerritsen, M, Nurmohamed, M T, Giannattasio, C, Tausche, A-K & Borghi, C 2022, ' Effects of intensive urate lowering therapy with febuxostat in comparison with allopurinol on pulse wave velocity in patients with gout and increased cardiovascular risk : the FORWARD study ', European heart journal. Cardiovascular pharmacotherapy, vol. 8, no. 3, pp. 236-242 . https://doi.org/10.1093/ehjcvp/pvaa144
European heart journal. Cardiovascular pharmacotherapy, 8(3), 236-242. Oxford University Press
Aims Hyperuricaemia and gout are strongly related with traditional cardiovascular risk factors and vascular damage. This study aimed to assess whether febuxostat and allopurinol could differently influence carotid-femoral pulse wave velocity (cfPWV)
Publikováno v:
Arterial Hypertension. 25:100-105
Arterial hypertension is a leading preventable cardiovascular risk factor. The definition and thresholds for the diagnosis of hypertension vary between European and American guidelines. That is mainly due to the widely known SPRINT trial in which una
Autor:
Lutgarde Thijs, Katarzyna Stolarz-Skrzypek, Gladys E. Maestre, Luk Buyse, Carina Mels, Zhenyu Zhang, Upright-Htm Investigators, Thomas Vanassche, Natasza Gilis-Malinowska, Advisors, Elisabeth S Muxfeldt, Marek Rajzer, Raymond Vanholder, Urinary Proteomics Centres, Peter Verhamme, Jesus D. Melgarejo, and Recruiting, Krzysztof Narkiewicz, Ruan Kruger, Fabio de Souza, Jana Brguljan-Hitij, Aletta E. Schutte, Jan A. Staessen, Yi-Wen Tsai, Tine W. Hansen, Dong-Mei Wei, Kalina Kawecka-Jaszcz, Gontse G. Mokwatsi, Hao-Min Cheng, Augustine N. Odili, Harald Mischak, Logistic Coordinating, Kei Asayama
Publikováno v:
BLOOD PRESSURE
BACKGROUND: Hypertension and diabetes cause chronic kidney disease (CKD) and diastolic left ventricular dysfunction (DVD) as forerunners of disability and death. Home blood pressure telemonitoring (HTM) and urinary peptidomic profiling (UPP) are tech